Tag: Prescription Drugs
Low Doses of Bevacizumab Tested for Retinopathy of Prematurity
Phase 1 study suggests that intravitreous injection of 0.004 mg may be lowest effective dose
COVID-19-Linked Changes Reported in Rheumatic Disease Patient Care
Forty-two percent of patients report change in care in previous two weeks
FDA Warns About Treating COVID-19 With Unproven Drugs
Chloroquine, hydroxychloroquine may trigger potentially fatal heart rhythm problems in COVID-19 patients
Clascoterone Cream Safe, Effective for Acne Treatment
Clascoterone cream, 1 percent, is a novel topical androgen receptor inhibitor
Lopinavir/Ritonavir, Umifenovir Ineffective for Mild COVID-19
Rate of positive-to-negative conversion of SARS-CoV-2 did not differ for drug therapy versus standard care
ACEIs/ARBs Not Linked to Severity or Mortality of COVID-19
Percentage of patients with hypertension taking ACEIs/ARBs similar for survivors, nonsurvivors
Expert Panel: There Are No Proven Drug Treatments for COVID-19
Whenever possible, drugs should be given to COVID-19 patients as part of a clinical trial
Hydroxychloroquine Seems Not to Cut Ventilator Use in COVID-19
Risk for death from any cause higher for HC alone, similar for HC+AZ compared with no HC
Physicians Report Low Interest in Opioid Use Disorder Meds
Few PCPs report obtaining buprenorphine waiver orprescribing buprenorphine, naltrexone for OUD
IDSA Issues Rapid Guidelines for Treatment of COVID-19
Expert panel urges that treatments for COVID-19 be given in the context of clinical trials
